As of 2025-07-03, the Intrinsic Value of Vincerx Pharma Inc (VINC) is -53.20 USD. This VINC valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.10 USD, the upside of Vincerx Pharma Inc is -53,300.00%.
Based on its market price of 0.10 USD and our intrinsic valuation, Vincerx Pharma Inc (VINC) is overvalued by 53,300.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -53.20 - -53.20 | -53.20 | -53,300.00% |
| P/E | (181.09) - (251.10) | (224.24) | -224337.5% |
| DDM - Stable | (65.08) - (189.00) | (127.04) | -127137.9% |
| DDM - Multi | (52.54) - (125.62) | (74.89) | -74986.3% |
| Market Cap (mil) | 0.28 |
| Beta | -1.79 |
| Outstanding shares (mil) | 2.83 |
| Enterprise Value (mil) | -4.70 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.26% |
| Cost of Debt | 5.00% |
| WACC | 7.96% |